ATE385253T1 - Nhibitor-resistente hcv ns3 protease - Google Patents
Nhibitor-resistente hcv ns3 proteaseInfo
- Publication number
- ATE385253T1 ATE385253T1 AT03770808T AT03770808T ATE385253T1 AT E385253 T1 ATE385253 T1 AT E385253T1 AT 03770808 T AT03770808 T AT 03770808T AT 03770808 T AT03770808 T AT 03770808T AT E385253 T1 ATE385253 T1 AT E385253T1
- Authority
- AT
- Austria
- Prior art keywords
- protease
- resistant
- inhibitor
- hcv
- nhibitor
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title abstract 3
- 239000004365 Protease Substances 0.000 title abstract 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 abstract 4
- 101800001838 Serine protease/helicase NS3 Proteins 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000009877 rendering Methods 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Materials For Photolithography (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42194302P | 2002-10-29 | 2002-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE385253T1 true ATE385253T1 (de) | 2008-02-15 |
Family
ID=32230287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03770808T ATE385253T1 (de) | 2002-10-29 | 2003-10-24 | Nhibitor-resistente hcv ns3 protease |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7208309B2 (de) |
| EP (1) | EP1558730B1 (de) |
| JP (1) | JP4295222B2 (de) |
| AT (1) | ATE385253T1 (de) |
| AU (1) | AU2003280239B2 (de) |
| CA (1) | CA2498653C (de) |
| DE (1) | DE60318954T2 (de) |
| DK (1) | DK1558730T3 (de) |
| ES (1) | ES2298585T3 (de) |
| IL (1) | IL168254A (de) |
| MX (1) | MXPA05004276A (de) |
| NZ (1) | NZ540292A (de) |
| WO (1) | WO2004039970A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005000308A2 (en) * | 2003-05-15 | 2005-01-06 | Rigel Pharmaceuticals, Inc. | Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c |
| EP1678202B1 (de) * | 2003-10-27 | 2012-06-13 | Vertex Pharmaceuticals Incorporated | Resistente hcv-ns3/ns4a-proteasemutanten |
| RS51243B (sr) | 2004-01-30 | 2010-12-31 | Medivir Ab. | Inhibitori ns-3 serina hcv proteaze |
| EP1874952A2 (de) * | 2005-04-11 | 2008-01-09 | Achillion Pharmaceuticals, Inc. | Pharmazeutische zusammensetzungen und verfahren zur hemmung der hcv-replikation |
| US7465537B2 (en) * | 2005-05-01 | 2008-12-16 | The Board Of Trustees Of The University Of Arkansas | Compounds and methods for inhibiting hepatitis C virus replication |
| WO2007014174A2 (en) * | 2005-07-25 | 2007-02-01 | Gilead Sciences, Inc. | Drug-resistant mutants of hepatitis c virus |
| PE20070211A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| US7705138B2 (en) | 2005-11-11 | 2010-04-27 | Vertex Pharmaceuticals Incorporated | Hepatitis C virus variants |
| EP2392589A3 (de) | 2005-11-11 | 2012-06-20 | Vertex Pharmaceuticals Incorporated | Hepatitis-C-Virusvarianten |
| WO2008046923A2 (en) | 2006-10-20 | 2008-04-24 | Innogenetics N.V. | Methodology for analysis of sequence variations within the hcv ns3/4a genomic region |
| US20100143886A1 (en) * | 2007-03-09 | 2010-06-10 | Ludmerer Steven W | In vivo hcv resistance to anti-viral inhibitors |
| US8298541B2 (en) * | 2007-03-29 | 2012-10-30 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae |
| WO2010028347A2 (en) | 2008-09-05 | 2010-03-11 | President & Fellows Of Harvard College | Continuous directed evolution of proteins and nucleic acids |
| WO2012088381A2 (en) | 2010-12-22 | 2012-06-28 | President And Fellows Of Harvard College | Continuous directed evolution |
| JP2014522647A (ja) | 2011-07-06 | 2014-09-08 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｃｖ遺伝子型４レプリコン |
| EP2729489A1 (de) * | 2011-07-06 | 2014-05-14 | Gilead Sciences, Inc. | Hcv-genotyp-3-replikons |
| US10179911B2 (en) | 2014-01-20 | 2019-01-15 | President And Fellows Of Harvard College | Negative selection and stringency modulation in continuous evolution systems |
| WO2016077052A2 (en) | 2014-10-22 | 2016-05-19 | President And Fellows Of Harvard College | Evolution of proteases |
| WO2016168631A1 (en) | 2015-04-17 | 2016-10-20 | President And Fellows Of Harvard College | Vector-based mutagenesis system |
| US10392674B2 (en) | 2015-07-22 | 2019-08-27 | President And Fellows Of Harvard College | Evolution of site-specific recombinases |
| US11524983B2 (en) | 2015-07-23 | 2022-12-13 | President And Fellows Of Harvard College | Evolution of Bt toxins |
| WO2017019895A1 (en) | 2015-07-30 | 2017-02-02 | President And Fellows Of Harvard College | Evolution of talens |
| US11447809B2 (en) | 2017-07-06 | 2022-09-20 | President And Fellows Of Harvard College | Evolution of tRNA synthetases |
| WO2019040935A1 (en) | 2017-08-25 | 2019-02-28 | President And Fellows Of Harvard College | EVOLUTION OF PEPTIDASES BONT |
| WO2019056002A1 (en) | 2017-09-18 | 2019-03-21 | President And Fellows Of Harvard College | CONTINUOUS EVOLUTION FOR STABILIZED PROTEINS |
| US11913044B2 (en) | 2018-06-14 | 2024-02-27 | President And Fellows Of Harvard College | Evolution of cytidine deaminases |
| WO2020205510A1 (en) | 2019-03-29 | 2020-10-08 | Trustees Of Boston University | Chimeric antigen receptor (car) modulation |
| WO2022020431A2 (en) | 2020-07-21 | 2022-01-27 | Trustees Of Boston University | Inducible control of gene expression |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843752A (en) * | 1995-05-12 | 1998-12-01 | Schering Corporation | Soluble active hepatitis C virus protease |
| IT1277914B1 (it) * | 1995-08-22 | 1997-11-12 | Angeletti P Ist Richerche Bio | Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e |
| US5990276A (en) * | 1996-05-10 | 1999-11-23 | Schering Corporation | Synthetic inhibitors of hepatitis C virus NS3 protease |
| US6608027B1 (en) * | 1999-04-06 | 2003-08-19 | Boehringer Ingelheim (Canada) Ltd | Macrocyclic peptides active against the hepatitis C virus |
| UA74546C2 (en) * | 1999-04-06 | 2006-01-16 | Boehringer Ingelheim Ca Ltd | Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition |
| US6326137B1 (en) * | 1999-06-25 | 2001-12-04 | Schering Corporation | Hepatitis C virus protease-dependent chimeric pestivirus |
| US6986892B1 (en) * | 1999-11-24 | 2006-01-17 | Chiron Corporation | Immunogenic Hepatitis C virus non-structural polypeptides |
| US20050074465A1 (en) * | 1999-11-24 | 2005-04-07 | Michael Houghton | HCV fusion proteins with modified NS3 domains |
| ES2287074T3 (es) * | 2000-12-22 | 2007-12-16 | Boehringer Ingelheim (Canada) Ltd. | Molecula de rna autorreplicante del virus de la hepatitis c. |
| AU2002254077A1 (en) * | 2001-02-28 | 2002-09-12 | Michael A. Hanson | Small molecule design against drug resistant mutants using directed evolution |
| EP1678202B1 (de) | 2003-10-27 | 2012-06-13 | Vertex Pharmaceuticals Incorporated | Resistente hcv-ns3/ns4a-proteasemutanten |
-
2003
- 2003-10-24 ES ES03770808T patent/ES2298585T3/es not_active Expired - Lifetime
- 2003-10-24 WO PCT/CA2003/001636 patent/WO2004039970A1/en not_active Ceased
- 2003-10-24 EP EP03770808A patent/EP1558730B1/de not_active Expired - Lifetime
- 2003-10-24 AT AT03770808T patent/ATE385253T1/de active
- 2003-10-24 AU AU2003280239A patent/AU2003280239B2/en not_active Expired
- 2003-10-24 MX MXPA05004276A patent/MXPA05004276A/es active IP Right Grant
- 2003-10-24 NZ NZ540292A patent/NZ540292A/en not_active IP Right Cessation
- 2003-10-24 DE DE60318954T patent/DE60318954T2/de not_active Expired - Lifetime
- 2003-10-24 DK DK03770808T patent/DK1558730T3/da active
- 2003-10-24 CA CA2498653A patent/CA2498653C/en not_active Expired - Lifetime
- 2003-10-24 JP JP2004547307A patent/JP4295222B2/ja not_active Expired - Lifetime
- 2003-10-28 US US10/695,140 patent/US7208309B2/en not_active Expired - Lifetime
-
2005
- 2005-04-27 IL IL168254A patent/IL168254A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006503584A (ja) | 2006-02-02 |
| JP4295222B2 (ja) | 2009-07-15 |
| AU2003280239A1 (en) | 2004-05-25 |
| IL168254A (en) | 2010-11-30 |
| CA2498653A1 (en) | 2004-05-13 |
| EP1558730A1 (de) | 2005-08-03 |
| AU2003280239B2 (en) | 2009-03-12 |
| MXPA05004276A (es) | 2005-08-03 |
| DK1558730T3 (da) | 2008-05-26 |
| WO2004039970A1 (en) | 2004-05-13 |
| EP1558730B1 (de) | 2008-01-30 |
| CA2498653C (en) | 2010-12-14 |
| DE60318954T2 (de) | 2009-01-22 |
| NZ540292A (en) | 2006-09-29 |
| US20050019753A1 (en) | 2005-01-27 |
| ES2298585T3 (es) | 2008-05-16 |
| DE60318954D1 (de) | 2008-03-20 |
| US7208309B2 (en) | 2007-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1558730T3 (da) | Inhibitorresistent HCV-NS3-protease | |
| WO2004101602A3 (en) | Hepatitis c inhibitor peptide analogs | |
| EP1771454A4 (de) | Peptidanaloga als hepatitis c-hemmer | |
| IL162815A0 (en) | Novel peptides as ns3-serine protease inhibitors of hepatitis c virus | |
| IL152022A0 (en) | Compounds useful as protease inhibitors and pharmaceutical compositions containing the same | |
| WO2007016476A3 (en) | Hepatitis c serine protease inhibitors and uses therefor | |
| DE122012000004I1 (de) | Peptide als inhibitoren der NS3-Serinprotease des hepatitis c virus. | |
| BR0211623A (pt) | Agentes de contraste alvos multiméricos com base em peptìdeo | |
| JP2005511541A5 (ja) | プロリン後切断プロテアーゼの阻害剤 | |
| ATE547412T1 (de) | Inhibitoren von serinproteasen, insbesondere hcv- ns3-ns4a-protease | |
| UY27972A1 (es) | Derivados de hidantoína | |
| EA200400986A1 (ru) | Гетероциклические трипептиды в качестве ингибиторов вируса гепатита c | |
| CY1109779T1 (el) | Αναστολεις της hcv ns-3 πρωτεασης σερινης | |
| WO2003064455A3 (en) | Macrocyclic peptides active against the hepatitis c virus | |
| WO2002048116A3 (en) | Inhibitors of hepatitis c virus ns3 protease | |
| IL176237A0 (en) | Inhibitors of hepatitis c virus ns3/ns4a serine protease | |
| LU91680I2 (fr) | "rilonacept et ses dérivés pharmaceutiquement acceptables (ARCALYSR)" | |
| UA83046C2 (ru) | Соединения как ингибиторы вируса гепатита с, фармацевтическая композиция на их основе | |
| SE0201976D0 (sv) | Novel compounds | |
| IL156774A0 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| Bondebjerg et al. | Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors | |
| BRPI0410861A (pt) | métodos e composições para a produção de aminoácidos | |
| Bennett et al. | The identification of α-ketoamides as potent inhibitors of hepatitis c virus nS3-4a proteinase | |
| AU2003277891A1 (en) | Hcv ns-3 serine protease inhibitors | |
| WO2003095475A3 (en) | Peptide compounds and their use as protease substrates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1558730 Country of ref document: EP |